Mesa Laboratories Inc balance sheet

At the end of fiscal 2026, Mesa Laboratories Inc had total assets of $428m, total liabilities of $242m and shareholders' equity of $186m. It held $26.9m in cash against $67.5m of debt: net debt of $40.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Mesa Laboratories Inc: balance sheet, annual
Fiscal year	2011Mar 2011	2012Mar 2012	2013Mar 2013	2014Mar 2014	2015Mar 2015	2016Mar 2016	2017Mar 2017	2018Mar 2018	2019Mar 2019	2020Mar 2020	2021Mar 2021	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026	LTMJun 2026
Cash and equivalents	4	7	4	6	2	6	6	5	10	81	264	49	33	28	27	27	31
Receivables	7	6	8	9	12	15	14	14	13	21	24	41	43	39	42	44	34
Inventory	6	4	6	8	12	14	14	9	7	11	11	25	35	33	25	26	27
Total current assets	17	19	19	27	30	37	36	32	34	123	304	124	119	109	103	106	103
Goodwill	14	14	24	38	45	66	72	66	66	142	161	291	286	180	182	187	186
Total assets	51	51	98	98	117	161	172	164	157	409	601	707	662	447	433	428	419
Accounts payable	1	1	1	2	3	3	2	2	3	3	4	8	6	6	6	5	7
Deferred revenue (current)	—	—	—	2	1	3	4	4	4	7	9	14	16	15	15	15	15
Total current liabilities	10	4	5	10	15	24	17	17	24	26	33	48	43	44	164	62	57
Short-term debt	5	—	0	0	3	3	1	2	2	—	—	—	—	—	—	—	—
Long-term debt	2	—	4	17	23	42	54	45	21	—	—	—	—	—	71	68	66
Total debt	11	2	4	17	26	45	55	46	23	140	146	169	170	171	164	68	66
Total liabilities	14	7	13	33	44	76	74	65	45	189	195	314	268	301	274	242	230
Shareholders' equity	36	44	53	64	73	85	98	99	111	220	406	394	393	145	160	186	189
Non-controlling interests and other (assets − liabilities − equity)	—	—	32	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net debt (negative = net cash)	7	−5	−0	11	24	40	49	41	13	59	−118	120	137	143	137	41	35
Shares outstanding	3m	3m	3m	3m	4m	4m	4m	4m	4m	4m	5m	5m	5m	5m	5m	6m	6m

US$ millions unless shown otherwise. Fiscal quarters.

Mesa Laboratories Inc: balance sheet, quarterly
Quarter	2025 Q2Sept 2024	2025 Q3Dec 2024	2025 Q4Mar 2025	2026 Q1Jun 2025	2026 Q2Sept 2025	2026 Q3Dec 2025	2026 Q4Mar 2026	2027 Q1Jun 2026
Receivables	40	42	42	39	40	40	44	34
Inventory	30	25	25	28	28	27	26	27
Total current assets	108	103	103	98	97	106	106	103
Goodwill	184	182	182	188	188	189	187	186
Total assets	454	433	433	436	430	435	428	419
Accounts payable	6	6	6	6	5	5	5	7
Deferred revenue (current)	14	15	15	15	14	15	15	15
Total current liabilities	153	164	164	149	48	54	62	57
Long-term debt	73	72	71	70	69	68	68	66
Total debt	73	72	71	70	69	68	68	66
Total liabilities	293	274	274	263	252	248	242	230
Shareholders' equity	161	155	160	172	178	187	186	189
Shares outstanding	5m	5m	5m	6m	6m	6m	6m	6m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: MLAB vs SDGR MLAB vs MRVI CTKB vs MLAB FLGT vs MLAB

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Mesa Laboratories Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mesa Laboratories Inc.